methamphetamine has been researched along with melatonin in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.33) | 18.7374 |
| 1990's | 5 (11.63) | 18.2507 |
| 2000's | 6 (13.95) | 29.6817 |
| 2010's | 23 (53.49) | 24.3611 |
| 2020's | 8 (18.60) | 2.80 |
| Authors | Studies |
|---|---|
| Nagao, M; Takatori, T; Terazawa, K | 1 |
| Arendt, J; Baumann, J; Degen, P; Feer, H; Haeusler, A; Kraeuchi, K; Morimasa, T; Wirz-Justice, A | 1 |
| Bush, L; Gibb, JW; Hanson, GR | 1 |
| Ali, SF; Black, MD; Itzhak, Y; Martin, JL | 2 |
| Asanuma, M; Cadet, JL; Hirata, H | 1 |
| Abe, H; Honma, K; Honma, S; Ikeda, M; Ishizaki, K; Masubuchi, S; Namihira, M | 1 |
| Champney, TH; Chen, WJ; Manzana, EJ | 1 |
| Chen, C; Cherng, CF; Yu, L | 1 |
| Govitrapong, P; Kongsuphol, P; Mukda, S; Nopparat, C; Villarroel, A | 1 |
| Chetsawang, B; Govitrapong, P; Phansuwan-Pujito, P; Wisessmith, W | 1 |
| Govitrapong, P; Kaewsuk, S; Phansuwan-Pujito, P; Sae-ung, K | 1 |
| Chetsawang, B; Govitrapong, P; Phansuwan-Pujito, P; Suwanjang, W | 1 |
| Chongthammakun, S; Govitrapong, P; Khonthun, C; Tocharus, J | 1 |
| Ebadi, M; Govitrapong, P; Nopparat, C; Porter, JE | 1 |
| Dubocovich, ML; Hudson, RL; Hutchinson, AJ | 1 |
| Govitrapong, P; Permpoonputtana, K | 1 |
| Charngkaew, K; Chetsawang, B; Govitrapong, P; Parameyong, A | 1 |
| Dubocovich, ML; Hudson, RL; Hutchinson, AJ; Liu, J; Ma, J | 1 |
| Govitrapong, P; Jumnongprakhon, P; Tocharus, C; Tocharus, J; Tungkum, W | 2 |
| Clough, SJ; Dubocovich, ML; Hudson, RL; Hutchinson, AJ | 1 |
| Govitrapong, P; Wongprayoon, P | 3 |
| Cho, HJ; Dang, DK; Hong, JS; Jang, CG; Jeong, JH; Kim, HC; Lee, J; Lee, JC; Nabeshima, T; Nam, Y; Nguyen, TT; Nguyen, XK; Park, DH; Shin, EJ | 1 |
| Ekthuwapranee, K; Govitrapong, P; Sotthibundhu, A | 1 |
| Govitrapong, P; Jumnongprakhon, P; Pinkaew, D; Tocharus, C; Tocharus, J | 1 |
| Chetsawang, B; Govitrapong, P; Parameyong, A | 1 |
| Boontem, P; Chetsawang, B; Ekthuwapranee, K; Govitrapong, P; Mukda, S; Singhakumar, R; Sotthibundhu, A | 1 |
| Li, G; Liu, Z; Sun, J; Wu, J; Zhang, J; Zhu, D | 1 |
| Govitrapong, P; Jumnongprakhon, P; Tocharus, C; Tocharus, J | 2 |
| Govitrapong, P; Jumnongprakhon, P; Sivasinprasasn, S; Tocharus, C; Tocharus, J | 1 |
| Chen, J; Li, S; Wang, X; Wang, Y; Wang, Z; Zhai, H | 1 |
| Govitrapong, P; Namyen, J; Nopparat, C; Permpoonputtana, K; Tocharus, C; Tocharus, J | 1 |
| Chetsawang, B; Hein, ZM; Kraiwattanapirom, N; Mukda, S | 1 |
| Chancharoen, P; Govitrapong, P; Lwin, T; Mukda, S; Ngampramuan, S; Pinyomahakul, J; Veschsanit, N; Viwatpinyo, K; Yang, JL | 1 |
| Chancharoen, P; Govitrapong, P; Lwin, T; Mukda, S; Ngampramuan, S; Pinyomahakul, J; Rungruang, S; Veschsanit, N; Viwatpinyo, K; Yang, JL | 1 |
| Govitrapong, P; Namyen, J; Nopparat, C; Panmak, P; Permpoonpattana, K | 1 |
| Chetsawang, B; Harnpramukkul, A; Komlao, P; Kraiwattanapirom, N; Ngampramuan, S; Promyo, K | 1 |
| Boontor, A; Govitrapong, P; Nopparat, C; Panmanee, J | 1 |
| Chetsawang, B; Cornish, JL; Na Nakorn, P; Ngampramuan, S; Panmanee, J; Pannengpetch, S; Polvat, T; Prasertporn, T; Suwanjang, W | 1 |
1 review(s) available for methamphetamine and melatonin
| Article | Year |
|---|---|
Melatonin Attenuates Methamphetamine-Induced Neurotoxicity.
Topics: Adult; Animals; Central Nervous System Depressants; Central Nervous System Stimulants; Humans; Melatonin; Methamphetamine; Neurotoxicity Syndromes; Rats | 2016 |
42 other study(ies) available for methamphetamine and melatonin
| Article | Year |
|---|---|
Monoclonal antibodies against haptens.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Diquat; Enzyme-Linked Immunosorbent Assay; Haptens; Melatonin; Methamphetamine; Mice; Mice, Inbred BALB C; Paraquat; Radioimmunoassay | 1992 |
Chronic methamphetamine and its withdrawal modify behavioral and neuroendocrine circadian rhythms.
Topics: Animals; Behavior, Animal; Body Temperature; Circadian Rhythm; Corticosterone; Drinking; Eating; Male; Melatonin; Methamphetamine; Motor Activity; Neurosecretory Systems; Rats; Rats, Inbred Strains; Thyrotropin | 1987 |
Exacerbation of methamphetamine-induced neurochemical deficits by melatonin.
Topics: Animals; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Male; Melatonin; Methamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Tryptophan Hydroxylase | 1997 |
Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
Topics: Animals; Body Temperature; Carrier Proteins; Dopamine; Dopamine Plasma Membrane Transport Proteins; Male; Melatonin; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Motor Activity; MPTP Poisoning; Neostriatum; Nerve Tissue Proteins | 1998 |
Melatonin attenuates methamphetamine-induced toxic effects on dopamine and serotonin terminals in mouse brain.
Topics: Animals; Antioxidants; Autoradiography; Brain Chemistry; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Iodine Radioisotopes; Male; Melatonin; Methamphetamine; Mice; Neostriatum; Nerve Endings; Nucleus Accumbens; Serotonin | 1998 |
Neuroprotective role of melatonin in methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Drug Evaluation, Preclinical; Fever; Free Radical Scavengers; Melatonin; Methamphetamine; Mice; Neuroprotective Agents | 1999 |
Clock genes outside the suprachiasmatic nucleus involved in manifestation of locomotor activity rhythm in rats.
Topics: Animals; Biological Clocks; Cell Cycle Proteins; Circadian Rhythm; Cloning, Molecular; Female; Gene Expression Regulation; Melatonin; Methamphetamine; Motor Activity; Nuclear Proteins; Period Circadian Proteins; Rats; Rats, Wistar; Suprachiasmatic Nucleus; Transcription Factors | 2000 |
Acute melatonin and para-chloroamphetamine interactions on pineal, brain and serum serotonin levels as well as stress hormone levels.
Topics: Adrenocorticotropic Hormone; Amphetamine-Related Disorders; Animals; Brain; Corticosterone; Drug Interactions; Hydroxyindoleacetic Acid; Melatonin; Methamphetamine; Neurons; Neurotoxins; Oxidative Stress; p-Chloroamphetamine; Pineal Gland; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Stress, Physiological | 2001 |
Melatonin in concentrated ethanol and ethanol alone attenuate methamphetamine-induced dopamine depletions in C57BL/6J mice.
Topics: Animals; Antioxidants; Bicuculline; Brain Chemistry; Central Nervous System Depressants; Circadian Rhythm; Darkness; Dopamine; Dopamine Agents; Ethanol; Female; GABA Antagonists; GABA-A Receptor Antagonists; Lighting; Male; Melatonin; Methamphetamine; Mice; Mice, Inbred C57BL | 2002 |
Melatonin attenuates methamphetamine-induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells.
Topics: Adaptor Proteins, Signal Transducing; Antioxidants; Apoptosis; Autophagy; Cell Cycle Proteins; Cell Line, Tumor; Central Nervous System Stimulants; Humans; Melatonin; Methamphetamine; Microtubule-Associated Proteins; Neuroprotective Agents; Phosphoproteins; Phosphorylation; Protein Kinases; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases | 2009 |
Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells.
Topics: bcl-2-Associated X Protein; Caspase 3; Cell Count; Cell Death; Cell Line, Tumor; Cell Survival; Desipramine; Drug Interactions; Humans; Melatonin; Methamphetamine; Microscopy, Fluorescence; Mitochondria; Neuroblastoma; Neuroprotective Agents; Signal Transduction | 2009 |
Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Topics: Amphetamine-Related Disorders; Animals; Animals, Newborn; Antioxidants; Brain; Brain Chemistry; Central Nervous System Stimulants; Dopamine; Down-Regulation; Drug Interactions; Female; GAP-43 Protein; Melatonin; Methamphetamine; Neuroprotective Agents; Pregnancy; Prenatal Exposure Delayed Effects; Presynaptic Terminals; Rats; Rats, Wistar; Synaptophysin; Tyrosine 3-Monooxygenase; Wallerian Degeneration | 2009 |
The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells.
Topics: Calcium-Binding Proteins; Calpain; Cell Line, Tumor; Cell Survival; Humans; Melatonin; Methamphetamine; Neuroblastoma | 2010 |
Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines.
Topics: Analysis of Variance; Animals; Cell Line; Cell Survival; Cytokines; Melatonin; Methamphetamine; Microglia; Rats; Reactive Nitrogen Species; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy.
Topics: Analysis of Variance; Anthracenes; Autophagy; Blotting, Western; Cell Line, Tumor; Humans; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Melatonin; Methamphetamine; Microscopy, Confocal; Microtubule-Associated Proteins; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2 | 2010 |
Genetic deletion of MT(1) and MT(2) melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/HeN mice.
Topics: Animals; Behavior, Animal; Central Nervous System; Central Nervous System Sensitization; Central Nervous System Stimulants; Gene Deletion; Male; Melatonin; Methamphetamine; Mice; Mice, Inbred C3H; Mice, Knockout; Motor Activity; Photoperiod; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Time Factors | 2012 |
The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Survival; Central Nervous System Stimulants; Cytokines; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Humans; Melatonin; Methamphetamine; Neuroblastoma; NF-E2 Transcription Factor; NF-kappaB-Inducing Kinase; Nitric Oxide Synthase Type II; Protein Serine-Threonine Kinases; RNA, Messenger | 2013 |
Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma SH-SY5Y cells.
Topics: Cell Death; Cell Line, Tumor; Central Nervous System Depressants; Central Nervous System Stimulants; Dynamins; GTP Phosphohydrolases; Humans; Melatonin; Membrane Proteins; Methamphetamine; Microtubule-Associated Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Proteins; Neoplasm Proteins; Neuroblastoma; Neurons; Protein Multimerization | 2013 |
Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice.
Topics: Animals; Blotting, Western; Brain; Central Nervous System Stimulants; Circadian Rhythm; Darkness; Light; Male; Melatonin; Methamphetamine; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Receptor, Melatonin, MT1; Species Specificity; Tyrosine 3-Monooxygenase | 2014 |
Protective effect of melatonin on methamphetamine-induced apoptosis in glioma cell line.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Nucleus; Cell Nucleus Shape; Cytochromes c; Melatonin; Methamphetamine; Mitochondria; Neuroprotective Agents; Rats; Time Factors | 2014 |
Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant; Dose-Response Relationship, Drug; Locomotion; Male; Melatonin; Methamphetamine; Mice; Mice, Inbred C3H; Mice, Knockout; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Reward; Time Factors | 2014 |
Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene.
Topics: Animals; Antioxidants; Apoptosis; Dopamine; Dopamine Uptake Inhibitors; Liposomes; Melatonin; Methamphetamine; Mice; Mice, Knockout; Mitochondria; Neurodegenerative Diseases; Protein Kinase C-delta | 2015 |
Melatonin attenuates methamphetamine-induced inhibition of proliferation of adult rat hippocampal progenitor cells in vitro.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Proliferation; Cells, Cultured; Hippocampus; Male; Melatonin; Methamphetamine; Neural Stem Cells; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2015 |
Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Down-Regulation; Glioma; Melatonin; Methamphetamine; NF-E2-Related Factor 2; NF-kappa B; Rats; Up-Regulation | 2015 |
Melatonin attenuates the mitochondrial translocation of mitochondrial fission proteins and Bax, cytosolic calcium overload and cell death in methamphetamine-induced toxicity in neuroblastoma SH-SY5Y cells.
Topics: bcl-2-Associated X Protein; Calcium; Cell Line; Cell Survival; Humans; Melatonin; Methamphetamine; Mitochondria; Mitochondrial Dynamics; Mitochondrial Proteins; Neurons; Protein Transport | 2015 |
Melatonin attenuates methamphetamine-induced neuroinflammation through the melatonin receptor in the SH-SY5Y cell line.
Topics: Antioxidants; Cell Line, Tumor; Central Nervous System Stimulants; Culture Media, Serum-Free; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Inflammation; Melatonin; Methamphetamine; Neuroblastoma; Protein Transport; Receptors, Melatonin; RNA, Small Interfering; Time Factors; Transfection; Tryptamines; Tumor Necrosis Factor-alpha | 2015 |
Melatonin attenuates methamphetamine-induced inhibition of neurogenesis in the adult mouse hippocampus: An in vivo study.
Topics: Animals; Cell Differentiation; Cell Proliferation; Central Nervous System Stimulants; Doublecortin Protein; Hippocampus; Male; MAP Kinase Signaling System; Melatonin; Methamphetamine; Mice, Inbred C57BL; Neural Stem Cells; Neurogenesis; Neurons; Protein Subunits; Receptors, N-Methyl-D-Aspartate | 2015 |
Melatonin treatment during the incubation of sensitization attenuates methamphetamine-induced locomotor sensitization and MeCP2 expression.
Topics: Animals; Blotting, Western; Central Nervous System Agents; Dose-Response Relationship, Drug; Male; Melatonin; Methamphetamine; Methyl-CpG-Binding Protein 2; Mice; Motor Activity; Nucleus Accumbens; PC12 Cells; Prefrontal Cortex; Rats | 2016 |
Melatonin promotes blood-brain barrier integrity in methamphetamine-induced inflammation in primary rat brain microvascular endothelial cells.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Encephalitis; Endothelial Cells; Melatonin; Membrane Glycoproteins; Methamphetamine; NADPH Oxidase 2; NADPH Oxidases; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Primary Cell Culture; Rats; Receptors, Melatonin; Signal Transduction | 2016 |
Melatonin Protects SH-SY5Y Neuronal Cells Against Methamphetamine-Induced Endoplasmic Reticulum Stress and Apoptotic Cell Death.
Topics: Antioxidants; Apoptosis; Blotting, Western; Caspase 12; Caspase 3; Cell Line, Tumor; Cell Survival; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Gene Expression; Humans; Melatonin; Methamphetamine; Neurons; Neuroprotective Agents; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2017 |
Inhibitory effect of melatonin on cerebral endothelial cells dysfunction induced by methamphetamine via NADPH oxidase-2.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain; Brain Diseases; Central Nervous System Stimulants; Cerebellum; Claudin-5; Endothelial Cells; Melatonin; Methamphetamine; NADP; NADPH Oxidases; Neuroprotective Agents; Occludin; Permeability; Rats; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species; Tight Junctions; Zonula Occludens-1 Protein | 2016 |
Melatonin suppresses methamphetamine-triggered endoplasmic reticulum stress in C6 cells glioma cell lines.
Topics: Activating Transcription Factor 6; Animals; Caspase 12; Cell Line, Tumor; Cell Survival; eIF-2 Kinase; Endoplasmic Reticulum Stress; Glioma; Heat-Shock Proteins; Melatonin; Membrane Proteins; Methamphetamine; Protein Serine-Threonine Kinases; Rats; Transcription Factor CHOP; X-Box Binding Protein 1 | 2017 |
Activation of melatonin receptor (MT1/2) promotes P-gp transporter in methamphetamine-induced toxicity on primary rat brain microvascular endothelial cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Cells, Cultured; Central Nervous System Stimulants; Endothelial Cells; Melatonin; Methamphetamine; Microvessels; Neuroprotective Agents; Rats; Reactive Nitrogen Species; Reactive Oxygen Species; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Rhodamine 123; Tryptamines; Verapamil | 2017 |
Melatonin pretreatment attenuates acute methamphetamine-induced aggression in male ICR mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aggression; Animals; Brain; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Melatonin; Methamphetamine; Mice; Mice, Inbred ICR; Serotonin | 2019 |
Protective Effects of Melatonin on Methamphetamine-Induced Blood-Brain Barrier Dysfunction in Rat Model.
Topics: Animals; Blood-Brain Barrier; Cell Adhesion; Hippocampus; Male; Melatonin; Methamphetamine; Neuroprotective Agents; Prefrontal Cortex; Rats, Wistar; Tight Junctions | 2020 |
The induction of Neuron-Glial2 (NG2) expressing cells in methamphetamine toxicity-induced neuroinflammation in rat brain are averted by melatonin.
Topics: Animals; Antigens; Brain; Central Nervous System Stimulants; Inflammation; Lipopolysaccharides; Male; Melatonin; Methamphetamine; Neuroglia; Neuroprotective Agents; Proteoglycans; Rats; Rats, Sprague-Dawley | 2020 |
Melatonin ameliorates methamphetamine-induced cognitive impairments by inhibiting neuroinflammation via suppression of the TLR4/MyD88/NFκB signaling pathway in the mouse hippocampus.
Topics: Animals; Anti-Inflammatory Agents; Central Nervous System Stimulants; Cognitive Dysfunction; Hippocampus; Inflammation; Melatonin; Methamphetamine; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Signal Transduction; Toll-Like Receptor 4 | 2021 |
Melatonin reverts methamphetamine-induced learning and memory impairments and hippocampal alterations in mice.
Topics: Animals; Central Nervous System Stimulants; Cognition; Hippocampus; Male; Maze Learning; Melatonin; Memory; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Neurons | 2021 |
Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Central Nervous System Stimulants; Cognitive Dysfunction; Hippocampus; Learning Disabilities; Male; Maze Learning; Melatonin; Memory Disorders; Methamphetamine; Neuroprotective Agents; Rats; Rats, Wistar | 2021 |
The neuroprotective role of melatonin against methamphetamine toxicity-induced neurotransmission dysregulation and cognitive deficits in rats.
Topics: Animals; Attention; Blotting, Western; Cognition; Cognition Disorders; Corpus Striatum; Hippocampus; Male; Melatonin; Methamphetamine; Neuroprotective Agents; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Synaptic Transmission | 2021 |
Melatonin Attenuates Methamphetamine-Induced Alteration of Amyloid β Precursor Protein Cleaving Enzyme Expressions via Melatonin Receptor in Human Neuroblastoma Cells.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Humans; Melatonin; Methamphetamine; Neuroblastoma; Neurodegenerative Diseases; Receptors, Melatonin | 2022 |
Proteomic Analysis Reveals the Neurotoxic Effects of Chronic Methamphetamine Self-Administration-Induced Cognitive Impairments and the Role of Melatonin-Enhanced Restorative Process during Methamphetamine Withdrawal.
Topics: Animals; Cognitive Dysfunction; Humans; Melatonin; Methamphetamine; Mice; Proteomics; Substance Withdrawal Syndrome | 2023 |